• Respite Care

    Relief for the primary  Weekend and Vacation Relief Accompaniment Services Attend religious Services Attend community events Visits to family and friends Accompaniment to physician or personal appointments

    read more
  • Nursing & Therapy

    Registered Nurses / LPN Physical Therapy Occupational Therapy Speech Therapy Nutritional Counseling Social Work Support

    read more
  • Homemaking & Errands

    Meal Preparation  Light housekeeping Laundry Errands and Shopping Prescriptions Pick up and Delivery Lawn care and snow removal House and Pet Sitting

    read more
  • Personal Care

        Bathing Dressing and Grooming Medication reminders Assistance with mobility, transfer & exercise

    read more
  • Companion Care

        Socialization Safety Supervision  24-Hour Live-In (Short Term and Long Term)

    read more

Prescription drug benefit doesn’t save money for Medicare

Researchers con­clude that Medicare Part D did not save the (Medicare) pro­gram any money overall


For years, the Medicare pre­scrip­tion drug ben­efit Part D has been cred­ited with pos­i­tively impacting national trends in health out­comes and med­ical ser­vices. But a recent study led by North­eastern asso­ciate pro­fessor Becky Briesacher chal­lenges that assump­tion and sug­gests that the U.S. Con­gres­sional Budget Office’s adopted a new costing method based on assumed cost-savings may be “premature.”


Since its imple­men­ta­tion in 2006, Part D has sub­stan­tially increased access to pre­scrip­tion drugs for the nearly 50 mil­lion Medicare sub­scribers. That increased access, though, has not led to a clear decrease in emer­gency room visits, hos­pital stays, inpa­tient costs, or mor­tality, according to the research by Briesacher and her team, which included col­leagues from Har­vard Med­ical School.


“We are con­cluding that Medicare Part D did not save the (Medicare) pro­gram any money overall,” said Briesacher, a health ser­vices researcher in the School of Phar­macy with nationally-recognized exper­tise in drug policy and med­ica­tion use in older adults. “You have to be real­istic about the fact that giving people access to med­ica­tion is impor­tant, but it’s not going to sub­stan­tially save money in other parts of the health care system or keep a sig­nif­i­cant number of people out of the hospital.”


The team pre­sented its results in a paper pub­lished Monday in Annals of Internal Med­i­cine.


About one year after Medicare Part D was launched, early studies were con­ducted among Medicare ben­e­fi­cia­ries who either had no pre­scrip­tion drug cov­erage or poor cov­erage prior to Part D. Those early studies found these spe­cific sub­groups saw sta­tis­ti­cally sig­nif­i­cant decreases in non­drug med­ical spending and hospitalizations.


But, as Briesacher explains, these selected sub­groups do not rep­re­sent the expe­ri­ences of Medicare sub­scribers at large, many of whom already had some type of drug cov­erage prior to Part D.


Briesacher and her team widened the scope of the analysis and looked at 11 years worth of data from the Medicare Cur­rent Ben­e­fi­ciary survey, which is an annual face-to-face panel survey of about 12,000 Medicare subscribers.


They found no sig­nif­i­cant change to sub­scribers reporting they were in poor to fair health five years after Part D was imple­mented. In 2006 that figure was 26.6 per­cent, while in 2010 it was 24.6 per­cent, which is sta­tis­ti­cally insignif­i­cant and which Briesacher con­tributes to pre-existing his­tor­ical trends.


Also, the emer­gency depart­ment trips and inpa­tient ser­vices stayed the same at about 13 per­cent for the entire study period.


The pre­vi­ously accepted early studies of Part D led the Con­gres­sional Budget Office, tasked with deter­mining the cost of leg­is­la­tion, to adopt an algo­rithm that works off the belief that increases in pre­scrip­tion fills across the Medicare pop­u­la­tion results in overall cost-offsets.


According to the paper, the CBO method­ology esti­mates Medicare spending on med­ical ser­vices is now rou­tinely reduced by 0.2 per­cent for each 1 per­cent increase in drug pre­scrip­tions filled.


The budget impact of the flawed method­ology is not trivial, according to the study. The researchers point to pro­vi­sions in the Afford­able Care Act to decrease Part D cost-sharing that are based on the Con­gres­sional Budget Office’s pre­dic­tion that Medicare’s non­drug spending will be reduced by $35 bil­lion through cost sav­ings in med­ical ser­vices, pri­marily decreases in hospitalization.


“We’d like the Con­gres­sional Budget Office to re-examine the policy,” Briesacher said. “It’s about prop­erly scoring the leg­is­la­tion so it doesn’t assume these cost-offsets that we can’t find.”

Written by Nicholas Loree

No Comments Yet.

Leave a Reply

Message

Contact Form Powered By : XYZScripts.com